Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

Figure 3 Prognostic value of the signature including 8 necroptosis-related long noncoding RNAs evaluated with Kaplan-Meier survival curves and receiver operating characteristic curves. A: The Kaplan-Meier (K-M) survival curves for the overall survival (OS) of patients in the high- and low-risk groups; B: The K-M survival curves for the disease-specific survival of patients in the high- and low-risk groups; C: The K-M survival curves for the progression-free interval of patients in the high- and low-risk groups; D: The K-M survival curves for the disease-free interval of patients in the high- and low-risk groups; E: The areas under the receiver operating characteristic curve (AUCs) of the RSs for 1-, 3- and 5-year OS; F: The AUCs of the RS for 1-year OS and for clinicopathological characteristics. 95%CI: 95% confidence interval; AUC: Areas under the receiver operating characteristic curve; DFI: Disease-free interval; DSS: Disease-specific survival; OS: Overall survival; PFI: Progression-free interval.